Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Pericardial Effusion × NOV 002 × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Pericardial Effusion 1 Ovarian Neoplasms 1 Myelodysplastic Syndromes 1 Leukemia 1 Inflammatory Breast Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Breast Neoplasms 1

Interventions

Pemetrexed 1 Paclitaxel 1 One-Lung Ventilation 1 NOV 002 1 Carboplatin 1 Bevacizumab 1 Anesthesia, General 1 Albumin-Bound Paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00347412 2022-07-25

Study of NOV-002 in Combination With Chemotherapy to Treat Lung Cancer

Cellectar Biosciences, Inc.

Phase 3 Completed

Carcinoma, Non-Small-Cell Lung, Pericardial Effusion

Data powered by HemOnc (CC BY 4.0) Colophon ⚡